%0 Journal Article %A Sepehr Golriz Khatami %A Maria Francesca Russo %A Daniel Domingo-Fernández %A Andrea Zaliani %A Sarah Mubeen %A Yojana Gadiya %A Astghik Sargsyan %A Reagon Karki %A Stephan Gebel %A Ram Kumar Ruppa Surulinathan %A Vanessa Lage-Rupprecht %A Saulius Archipovas %A Geltrude Mingrone %A Marc Jacobs %A Carsten Claussen %A Martin Hofmann-Apitius %A Alpha Tom Kodamullil %A the COPERIMOplus consortium %T Curating, collecting, and cataloguing global COVID-19 datasets for the aim of predicting personalized risk %D 2021 %R 10.1101/2021.11.14.21265797 %J medRxiv %P 2021.11.14.21265797 %X The COVID-19 data catalogue is a repository that provides a landscape view of COVID-19 studies and datasets as a putative source to enable researchers to develop personalized COVID-19 predictive risk models. The COVID-19 data catalogue currently contains over 400 studies and their relevant information collected from a wide range of global sources such as global initiatives, clinical trial repositories, publications and data repositories. Further, the curated content stored in this data catalogue is complemented by a web application, providing visualizations of these studies, including their references, relevant information such as measured variables, and the geographical locations of where these studies were performed. This resource is one of the first to capture, organize and store studies, datasets and metadata in the area of COVID-19 in a comprehensive repository. We are convinced that our work will facilitate future research and development of personalized predictive risk models of COVID-19.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was conducted in the context of the 'COPERIMOplus' initiative and supported by the Fraunhofer 'Internal Programs Fraunhofer vs Corona' under Grant No. Anti-Corona 840266.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Catholic University of the Sacred Heart gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data should be applied from Catholic University of the Sacred Heart %U https://www.medrxiv.org/content/medrxiv/early/2021/11/15/2021.11.14.21265797.full.pdf